EP 1007051 A1 20000614 - INTEGRIN RECEPTOR ANTAGONISTS
Title (en)
INTEGRIN RECEPTOR ANTAGONISTS
Title (de)
INTEGRIN REZEPTOR ANTAGONISTEN
Title (fr)
ANTAGONISTES DU RECEPTEUR DE L'INTEGRINE
Publication
Application
Priority
- US 9816246 W 19980804
- US 5470397 P 19970804
- US 6352697 P 19971029
Abstract (en)
[origin: WO9906049A1] Compounds of the formula (I) are disclosed which are dual fibrinogen receptor and vitronectin receptor antagonists and are useful in the treatment of atherosclerosis, in the prevention of restenosis and in the prevention of tumor metastasis and tumor growth.
IPC 1-7
A61K 31/55; C07D 223/16; C07D 243/14; C07D 267/14; C07D 281/10
IPC 8 full level
A61K 31/5513 (2006.01); A61K 31/553 (2006.01); A61K 31/554 (2006.01); A61P 9/10 (2006.01); A61P 43/00 (2006.01); C07D 223/16 (2006.01); C07D 267/14 (2006.01); C07D 281/10 (2006.01); C07D 401/14 (2006.01); C07D 403/14 (2006.01)
CPC (source: EP)
A61P 9/10 (2017.12); A61P 43/00 (2017.12); C07D 401/14 (2013.01)
Designated contracting state (EPC)
BE CH DE ES FR GB IT LI NL
DOCDB simple family (publication)
WO 9906049 A1 19990211; AU 8689798 A 19990222; CA 2298544 A1 19990211; EP 1007051 A1 20000614; EP 1007051 A4 20010829; JP 2001511452 A 20010814
DOCDB simple family (application)
US 9816246 W 19980804; AU 8689798 A 19980804; CA 2298544 A 19980804; EP 98938357 A 19980804; JP 2000504863 A 19980804